Pam Grady

Spectrum Health

Papers

1

Total Citations

20

H-Index

1

About

Dr. Pam Grady is a clinical researcher whose work focuses on the early detection and management of acute kidney injury (AKI), particularly in the context of urological surgery. Her most-cited study, a 2018 feasibility investigation, evaluated the utility of urinary renal biomarkers for predicting AKI following partial nephrectomy. This work addresses a critical gap in perioperative care, as early identification of kidney damage can significantly improve patient outcomes by enabling timely intervention. By demonstrating the potential of non-invasive biomarkers to forecast renal stress before standard clinical markers rise, Dr. Grady has contributed to a shift toward proactive, precision-based nephroprotection. Her research bridges nephrology and urology, offering practical insights for surgeons and anesthesiologists. With 20 citations, this study has informed subsequent trials and clinical protocols, underscoring its relevance in a field where early prediction remains a challenge. Dr. Grady’s work exemplifies how targeted, translational research can enhance surgical safety and reduce the burden of postoperative complications.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Evaluation of Urinary Renal Biomarkers for Early Prediction of Acute Kidney Injury Following Partial Nephrectomy: A Feasibility Study
20 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Spectrum Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago